Literature DB >> 24682799

The role of cardiac pacing in carotid sinus syndrome: a meta-analysis.

Bing-Wei Chen1, Zhi-Guang Wang, Na-Qiang Lv, Yan-Mei Cheng, Ai-Min Dang.   

Abstract

PURPOSE: Cardiac pacing can be used to treat carotid sinus syndrome (CSS), but clinical studies have shown conflicting results. We conducted a systematic review and meta-analysis to evaluate the role of pacing for CSS.
METHODS: A systematic search of publications in PubMed, Embase, and the Cochrane Library without language restriction was performed. Prospective randomized studies that compared cardiac pacing with standard therapy or pacing with different algorithms were included if the recurrence of syncope or the number of falls was observed.
RESULTS: Eight studies enrolling 540 patients were identified. In open-label studies, the recurrence of syncope was reduced significantly by cardiac pacing compared with standard therapy. The recurrence of syncope was not different between single- and dual-chamber pacing, but a lower rate of patients with pre-syncope was observed in the group with dual-chamber pacing. Double-blind clinical studies failed to observe the role of cardiac pacing for preventing falls in patients with CSS.
CONCLUSION: The results of meta-analysis supported the use of cardiac pacing for patients with dominant cardioinhibitory CSS.

Entities:  

Mesh:

Year:  2014        PMID: 24682799     DOI: 10.1007/s10286-014-0238-x

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  21 in total

Review 1.  Measuring inconsistency in meta-analyses.

Authors:  Julian P T Higgins; Simon G Thompson; Jonathan J Deeks; Douglas G Altman
Journal:  BMJ       Date:  2003-09-06

2.  The expectation effect and cardiac pacing for refractory vasovagal syncope.

Authors:  Sachin Sud; David Massel; George J Klein; Peter Leong-Sit; Raymond Yee; Allan C Skanes; Lorne J Gula; Andrew D Krahn
Journal:  Am J Med       Date:  2007-01       Impact factor: 4.965

3.  Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

Authors:  D Moher; B Pham; A Jones; D J Cook; A R Jadad; M Moher; P Tugwell; T P Klassen
Journal:  Lancet       Date:  1998-08-22       Impact factor: 79.321

4.  Natural and unnatural history of patients with severe carotid sinus hypersensitivity: a preliminary study.

Authors:  M Brignole; C Menozzi; G Lolli; B Sartore; M Barra
Journal:  Pacing Clin Electrophysiol       Date:  1988-11       Impact factor: 1.976

5.  Is DDD superior to VVI pacing in mixed carotid sinus syndrome? An acute and medium-term study.

Authors:  M Brignole; B Sartore; M Barra; C Menozzi; G Lolli
Journal:  Pacing Clin Electrophysiol       Date:  1988-11       Impact factor: 1.976

6.  Carotid sinus syndrome: a modifiable risk factor for nonaccidental falls in older adults (SAFE PACE).

Authors:  R A Kenny; D A Richardson; N Steen; R S Bexton; F E Shaw; J Bond
Journal:  J Am Coll Cardiol       Date:  2001-11-01       Impact factor: 24.094

7.  Less syncope and milder symptoms in patients treated with pacing for induced cardioinhibitory carotid sinus syndrome: a randomized study.

Authors:  Jan-Eric Claesson; Bo-Erik Kristensson; Nils Edvardsson; Peter Währborg
Journal:  Europace       Date:  2007-09-05       Impact factor: 5.214

8.  Pacing in elderly recurrent fallers with carotid sinus hypersensitivity: a randomised, double-blind, placebo controlled crossover trial.

Authors:  S W Parry; N Steen; R S Bexton; M Tynan; R A Kenny
Journal:  Heart       Date:  2009-01-05       Impact factor: 5.994

9.  [Comparison of permanent cardiac pacing and cardiac pacing on demand in mixed carotid sinus syndrome. Acute- and medium-term follow-up study].

Authors:  M Brignole; M Barra; B Sartore; C Menozzi; G Lolli
Journal:  G Ital Cardiol       Date:  1988-01

Review 10.  Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block.

Authors:  J Dretzke; W D Toff; G Y H Lip; J Raftery; A Fry-Smith; R Taylor
Journal:  Cochrane Database Syst Rev       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.